Abstract
The hypothesis that chemotherapy may be more effective when there is only a slight tumor burden has led to its use after mastectomy in patients at high risk of recurrence. The preliminary results of a trial of melphalan (l-PAM) as adjuvant therapy carried out by the National Surgical Adjuvant Breast Project (NSABP) [1], suggested that melphalan therapy could significantly prolong postoperative relapse-free survival (RFS). Because of the importance of these findings we decided, in March 1975, to repeat the trial at the breast unit at Guy’s Hospital. Results from the Istituto Nationale Tumori in Milan on the use of a combination of cyclophosphamide, methotrexate, and fluorouracil (CMF) in patients with involved axillary nodes after mastectomy [2] suggested that postoperative RFS could be prolonged by chemotherapy. These findings led to the establishment, in March 1976, of a three-armed trial in the University Hospital of South Manchester comparing no adjuvant treatment, melphalan, and CMF. Because of the similarity of protocols and interests at Guy’s Hospital and in Manchester, we decided in 1979 to amalgamate the trials. We now report the results of the combined randomised trial comparing adjuvant melphalan, adjuvant CMF, and no adjuvant therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fisher BF, Carbone P, Economou SG et al. (1975) L-phenylalanine mustard (L-PAM) in the management of primary breast cancer: a report of early findings. N Engl J Med 292: 117–122
Bonadonna G, Brusamolino E, Valagussa P et al. (1976) Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 294: 405–410
Hayward JL, Meakin JW, Stewart HJ (1978) Assessment of response and recurrence in breast cancer. Semin Oncol 5: 445–449
Peto R, Pike MC, Armitage P et al. (1977) Design and analysis of randomised clinical trials requiring prolonged observations of each patient. II. Analysis and examples. Br J Cancer 35: 1–39
King RJB, Redgrave S, Hayward JL, Millis RR, Rubens RD (1979) The measurement of receptors for oestrogen and progesteron in human breast tumours. In: King RJB (ed) Steroid receptor assays in human breast tumours. Methodological and clinical aspects. Alpha Omega, Cardiff
Barnes DM, Ribeiro GG, Skinner LG (1979) Simultaneous estimation of oestrogen and progestin receptor activity in human breast tumours and correlation with response to treatment. In: King RJB (ed) Steroid receptor assay in human breast tumours. Methodological and clinical aspects. Alpha Omega, Cardiff, pp 16–31
Maguire GP, Howat JMT, Sellwood RA, Tait A, Bush H (1980) The psychological morbidity associated with adjuvant chemotherapy following mastectomy in patients with breast cancer. Br Med J 281: 1179–1180
Bonadonna G, Rossi A, Tancini G, Valagussa P (1983) Adjuvant chemotherapy in breast cancer. Lancet 1: 1157
Howat JMT, Hughes R, Durning P, George WD, Sellwood RA, Bush H, Phadke K, Grafton C, Crowther D (1981) A controlled clinical trial of adjuvant chemotherapy in operable cancer of the breast. In: Salmon SE, Jones SE (eds) Adjuvant therapy of cancer III. Grune and Stratton, New York, p 71
Bonadonna G, Valagussa P (1981) Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med 304: 10–15
Tancini G, Bonadonna G, Valagussa P, Marchini S, Veronisi U (1983) Adjuvant CMF in breast cancer: comparative 5 year results of 12 versus 6 cycles. J Clin Oncol 1 /1: 2–10
Haworth C, Howell A, Testa NG (to be published) Long term bone marrow damage in patients treated with adjuvant chemotherapy
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Howell, A. et al. (1984). A Controlled Trial of Adjuvant Chemotherapy with Melphalan Versus Cyclophosphamide, Methotrexate, and Fluorouracil for Breast Cancer. In: Senn, HJ. (eds) Adjuvant Chemotherapy of Breast Cancer. Recent Results in Cancer Research, vol 96. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82357-2_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-82357-2_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-82359-6
Online ISBN: 978-3-642-82357-2
eBook Packages: Springer Book Archive